Hyaluronidase (Ingredient)
Drugbank ID: DB06205
ATC code: B06AA03
The information below refers to products available in the United States that contain hyaluronidase.
Products containing hyaluronidase
hyaluronidase systemic
Brand names: Hylenex, Vitrase, Amphadase, Wydase, Hydase
Drug class: miscellaneous uncategorized agents
Hyaluronidase systemic is used in the treatment of:
Multi-ingredient medications containing hyaluronidase
atezolizumab/hyaluronidase systemic
Brand name: Tecentriq Hybreza
Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
Atezolizumab/hyaluronidase systemic is used in the treatment of:
- Alveolar Soft Part Sarcoma
- Hepatocellular Carcinoma
- Melanoma
- Non Small Cell Lung Cancer
- Small Cell Lung Cancer
daratumumab/hyaluronidase systemic
Brand name: Darzalex Faspro
Drug class: CD38 monoclonal antibodies
Daratumumab/hyaluronidase systemic is used in the treatment of:
efgartigimod alfa/hyaluronidase systemic
Brand name: Vyvgart Hytrulo
Drug class: immune globulins
Efgartigimod alfa/hyaluronidase systemic is used in the treatment of:
hyaluronidase/immune globulin systemic
Brand name: Hyqvia
Drug class: immune globulins
Hyaluronidase/immune globulin systemic is used in the treatment of:
hyaluronidase/nivolumab systemic
Brand name: Opdivo Qvantig
Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
Hyaluronidase/nivolumab systemic is used in the treatment of:
- Colorectal Cancer
- Esophageal Carcinoma
- Gastric Cancer
- Head and Neck Cancer
- Hepatocellular Carcinoma
- Melanoma
- Non Small Cell Lung Cancer
- Renal Cell Carcinoma
- Urothelial Carcinoma
hyaluronidase/ocrelizumab systemic
Brand name: Ocrevus Zunovo
Drug class: CD20 monoclonal antibodies
Hyaluronidase/ocrelizumab systemic is used in the treatment of:
hyaluronidase/pertuzumab/trastuzumab systemic
Brand name: Phesgo
Drug class: HER2 inhibitors
Hyaluronidase/pertuzumab/trastuzumab systemic is used in the treatment of:
hyaluronidase/rituximab systemic
Brand name: Rituxan Hycela
Drug class: CD20 monoclonal antibodies
Hyaluronidase/rituximab systemic is used in the treatment of:
hyaluronidase/trastuzumab systemic
Brand name: Herceptin Hylecta
Drug class: HER2 inhibitors
Hyaluronidase/trastuzumab systemic is used in the treatment of:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.